Active Ingredient: MELOXICAM; RIZATRIPTAN BENZOATE
Proprietary Name: SYMBRAVO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG;EQ 10MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215431
Product Number: 001
Approval Date: Jan 30, 2025
Applicant Holder Full Name: AXSOME THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
